This blog post is just one of many in Signal’s seventh annual blog carnival discussing what hurdles need to be overcome for cell and gene therapies in clinical trials to reach the marketplace and whether the system is prepared.
Medicine by Design invests $1 million in Convergent Working Group projects to integrate new strands of inquiry and expand its community across sectors
Seven new projects will focus on equity, commercialization policy, new regenerative medicine applications and more
Convergent Working Groups bring new voices to Medicine by Design to explore ideas and opportunities in regenerative medicine
New initiative to include social scientists, policy experts, industry leaders, patients and others